Nagasaki, Japan

Sunao Atogami

This inventor holds 1 USPTO granted patent. Top assignee: Sysmex Corporation. Active years: 2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sunao Atogami. Retrieved from https://idiyas.com/inventor/sunao-atogami

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sunao Atogami: Innovator in Hematology

Introduction

Sunao Atogami is a notable inventor based in Nagasaki, Japan. He has made significant contributions to the field of hematology through his innovative work. His expertise lies in developing methods and devices that enhance the monitoring of red blood cell-related diseases.

Latest Patents

Atogami holds a patent for "Methods and devices for measuring reticulocytes." This invention describes techniques for monitoring therapeutic effects in red blood cell-related diseases by detecting the size of reticulocytes using a fully automatic blood cell counting device. His work is crucial for improving patient care in hematological conditions.

Career Highlights

Sunao Atogami is associated with Sysmex Corporation, a leading company in the field of medical diagnostics. His role at Sysmex has allowed him to focus on advancing technologies that aid in blood analysis and disease monitoring. His dedication to innovation has positioned him as a key figure in his field.

Collaborations

Atogami has collaborated with talented colleagues, including Toshihiro Mizukami and Yusuke Mori. These partnerships have fostered a creative environment that encourages the development of groundbreaking solutions in medical technology.

Conclusion

Sunao Atogami's contributions to the field of hematology through his patent and work at Sysmex Corporation highlight his commitment to improving healthcare. His innovative methods for measuring reticulocytes represent a significant advancement in monitoring red blood cell-related diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…